Adult T-cell Leukemia-derived Factor/thioredoxin, Produced by Both Human T-lymphotropic Virus Type I- and Epstein-Barr Virus-transformed Lymphocytes, Acts As an Autocrine Growth Factor and Synergizes with Interleukin 1 and Interleukin 2

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1990 Nov 1

PMID 2172979

Citations 54

Authors

N Wakasugi

Y Tagaya

H Wakasugi

A Mitsui

M Maeda

J Yodoi

T Tursz

Affiliations

Soon will be listed here.

Abstract

Interleukin 1 (IL-1) has been obtained from the Epstein-Barr virus-infected B-lymphoblastoid cell line 3B6 and shown to be involved in autocrine growth of 3B6 B cells. Independently, adult T-cell leukemia-derived factor (ADF) was purified from human T-lymphotropic virus I-infected leukemic T-cell line (ATL-2) and reported as an interleukin 2 (IL-2) receptor-inducing factor. We have previously reported the same molecular mass, pI, and NH2-terminal amino acid sequence for both 3B6-derived IL-1 and ADF. cDNA cloning of ADF demonstrated high homology with the prokaryotic disulfide reducing enzyme thioredoxin. We show here that ADF and 3B6-derived IL-1 are identical. By RNA blot, 3B6 and ATL-2 cells were shown to contain high levels of 0.6-kilobase mRNA corresponding to ADF. Such message was not detected in resting peripheral blood lymphocytes but could be weakly induced by lymphocyte activation. Antibodies have been raised against synthetic peptides corresponding to the NH2 terminus and the COOH terminus of ADF. Immunoblotting and sequential immunoprecipitation with these antibodies revealed the same 13-kDa protein in 3B6 and ATL-2 cells. Recombinant ADF could sustain growth of 3B6 and ATL-2 cells at low cellular concentration without fetal calf serum; ADF, thus, appears involved in their autocrine growth. Similarly, recombinant ADF could enhance growth of other B-cell lines, including the Epstein-Barr virus-negative Burkitt lymphoma line BL41 and the lymphoblastoid cell lines CRAG8, CRB95, and 1G8. Finally, recombinant ADF exhibits marked synergism with other cytokines, such as IL-1 and IL-2, allowing virally infected lymphocytes to respond to suboptimal amounts of a variety of growth factors.

Citing Articles

Thioredoxin VdTrx1, an unconventional secreted protein, is a virulence factor in .

Tian L, Zhuang J, Li J, Zhu H, Klosterman S, Dai X Front Microbiol. 2023; 14:1130468.

PMID: 37065139 PMC: 10102666. DOI: 10.3389/fmicb.2023.1130468.

Thioredoxin-1 regulates self-renewal and differentiation of murine hematopoietic stem cells through p53 tumor suppressor.

Jabbar S, Mathews P, Wang X, Sundaramoorthy P, Chu E, Piryani S Exp Hematol Oncol. 2022; 11(1):83.

PMID: 36316713 PMC: 9624023. DOI: 10.1186/s40164-022-00329-3.

Redox regulation of the immune response.

Morris G, Gevezova M, Sarafian V, Maes M Cell Mol Immunol. 2022; 19(10):1079-1101.

PMID: 36056148 PMC: 9508259. DOI: 10.1038/s41423-022-00902-0.

A Novel Thioredoxin-Like Protein of Involved in Parasite Pathogenicity.

Piao X, Ma Y, Liu S, Hou N, Chen Q Front Cell Infect Microbiol. 2022; 12:826818.

PMID: 35252036 PMC: 8892138. DOI: 10.3389/fcimb.2022.826818.

Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.

Sofi M, Wu Y, Schutt S, Dai M, Daenthanasanmak A, Heinrichs Voss J J Clin Invest. 2019; 129(7):2760-2774.

PMID: 31045571 PMC: 6597211. DOI: 10.1172/JCI122899.

References

Yodoi J, Takatsuki K, Masuda T . Letter: Two cases of T-cell chronic lymphocytic leukemia in Japan. N Engl J Med. 1974; 290(10):572-3. DOI: 10.1056/NEJM197403072901018. View

Teshigawara K, Maeda M, Nishino K, Nikaido T, Uchiyama T, Tsudo M . Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. J Mol Cell Immunol. 1985; 2(1):17-26. View

Sidman C, UNANUE E . Control of proliferation and differentiation in B lymphocytes by anti-Ig antibodies and a serum-derived cofactor. Proc Natl Acad Sci U S A. 1978; 75(5):2401-5. PMC: 392561. DOI: 10.1073/pnas.75.5.2401. View

Goodman M, Weigle W . Nonspecific activation of murine lymphocytes. V. Role of cellular collaboration between T and B lymphocytes in the proliferative and polyclonal response to 2-mercaptoethanol. J Immunol. 1979; 122(4):1433-9. View

Holmgren A . Reduction of disulfides by thioredoxin. Exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action. J Biol Chem. 1979; 254(18):9113-9. View

Uchiyama T, Broder S, Waldmann T . A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol. 1981; 126(4):1393-7. View

Gallo R, Wong-Staal F . Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis. Blood. 1982; 60(3):545-57. View

Grippo J, Tienrungroj W, Dahmer M, Housley P, Pratt W . Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem. 1983; 258(22):13658-64. View

Arya S, Wong-Staal F, Gallo R . T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells. Science. 1984; 223(4640):1086-7. DOI: 10.1126/science.6320374. View

10.

Scala G, Kuang Y, Hall R, Muchmore A, Oppenheim J . Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line. J Exp Med. 1984; 159(6):1637-52. PMC: 2187324. DOI: 10.1084/jem.159.6.1637. View

11.

Waldmann T, Goldman C, Robb R, Depper J, Leonard W, Sharrow S . Expression of interleukin 2 receptors on activated human B cells. J Exp Med. 1984; 160(5):1450-66. PMC: 2187491. DOI: 10.1084/jem.160.5.1450. View

12.

Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T . TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol. 1985; 134(3):1623-30. View

13.

Wakasugi H, Dokhelar M, Garson D, Harel-Bellan A, Fradelizi D, Tursz T . Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines. Eur J Immunol. 1985; 15(3):256-61. DOI: 10.1002/eji.1830150309. View

14.

Thorley-Lawson D, Mann K . Early events in Epstein-Barr virus infection provide a model for B cell activation. J Exp Med. 1985; 162(1):45-59. PMC: 2187697. DOI: 10.1084/jem.162.1.45. View

15.

Holmgren A . Thioredoxin. Annu Rev Biochem. 1985; 54:237-71. DOI: 10.1146/annurev.bi.54.070185.001321. View

16.

Maeda M, Shimizu A, Ikuta K, Okamoto H, Kashihara M, Uchiyama T . Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement. J Exp Med. 1985; 162(6):2169-74. PMC: 2187984. DOI: 10.1084/jem.162.6.2169. View

17.

Rimsky L, Wakasugi H, Ferrara P, Robin P, Capdevielle J, Tursz T . Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line. J Immunol. 1986; 136(9):3304-10. View

18.

Yodoi J, Uchiyama T . IL-2 receptor dysfunction and adult T-cell leukemia. Immunol Rev. 1986; 92:135-56. DOI: 10.1111/j.1600-065x.1986.tb01498.x. View

19.

Maruyama M, Shibuya H, Harada H, Hatakeyama M, Seiki M, Fujita T . Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell. 1987; 48(2):343-50. DOI: 10.1016/0092-8674(87)90437-5. View

20.

Wakasugi H, Rimsky L, Mahe Y, Kamel A, Fradelizi D, Tursz T . Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Proc Natl Acad Sci U S A. 1987; 84(3):804-8. PMC: 304304. DOI: 10.1073/pnas.84.3.804. View